0% found this document useful (0 votes)
13 views41 pages

Common Bleeding Disorders

Uploaded by

Ian
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
13 views41 pages

Common Bleeding Disorders

Uploaded by

Ian
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 41

Common Bleeding

Disorders
Dr Chanda Kapoma
Fifth Years
2 Objectives

 By the end of this lecture the student should be able to:


 Describe the basics of haemostasis
 Discuss the clinical manifestations of:
 ITP

 Haemophilia

 Vitamin K Deficiency Bleeding

 Mention the investigations and treatment of these disorders

Common Bleeding Disorders 27/02/2021


3 Presentation Outline

 Definition of Bleeding Disorders


 Stages of Coagulation
 Intrinsic and Extrinsic pathways of Coagulation
 Epidemiology of Bleeding Disorders
 ITP
 Haemophilia
 Vitamin K Deficient Bleeding

Common Bleeding Disorders 27/02/2021


4 What is haemostasis?

 Haemostasis is the prevention of blood loss

 Haemostasis is achieved by several mechanisms:


 Vascular constriction
 Formation of a platelet plug
 Formation of a blood clot
 Growth of fibrous tissue

Common Bleeding Disorders 27/02/2021


5 Steps of Coagulation

 Formation of the prothrombin activator

 Conversion of prothrombin into thrombin

 Conversion of fibrinogen into fibrin fibres

Common Bleeding Disorders 27/02/2021


6 Steps of Coagulation

Common Bleeding Disorders 27/02/2021


7 How is clotting initiated?

1. Extrinsic pathway
2. Intrinsic pathway

Common Bleeding Disorders 27/02/2021


8 Extrinsic pathway

Common Bleeding Disorders 27/02/2021


9

Intrinsic pathway

Common Bleeding Disorders 27/02/2021


10 Tissue Factor and Factor XII

 In the absence of calcium clotting does not take place


regardless of the pathway

 Tissue factor initiates the extrinsic pathway

 Contact of Factor XII and platelets with collagen in the


vascular wall initiates the intrinsic pathway

Common Bleeding Disorders 27/02/2021


11 Epidemiology of Bleeding Disorders

 The three most common hereditary bleeding disorders are Hemophilia A,


Hemophilia B and von Willebrand Disease

 The prevalence of Hemophilia increases where there are higher leves of


consanguinity

 Von Willibrand Disease is autosomal dominant with no predilection for sex

Common Bleeding Disorders 27/02/2021


12 Classification of Bleeding Disorders

Blood Vessel Platelet Abnormality Abnormal Coagulation


Abnormality
Scurvy Thrombocytopenia: Congenital:
• Malignancy • Haemophilia A
• Viral infections • Haemophilia B
• Marrow damage
due to drugs
• Aplastic Anaemia
• ITP
• DIC (Septicaemia)
Septic or Toxic Vasculitis: Abnormal Platelet Acquired:
• Meningococcemi Function: • Haemorrhagic Disease
a • Von Willebrand’s of the Newborn
• Yellow fever Disease
Common Bleeding Disorders 27/02/2021
Anaphylactoid purpura
(HSP)
13

What is ITP?

Common Bleeding Disorders 27/02/2021


14
Immune ThrombcytoPenia

 It is the most common platelet disorder in children

 It is characterized by isolated thrombocytopenia

 The cause remains unknown but it can be triggered by a viral


infection or other immunologic or environmental event

 It has an immune mediated mechanism

Common Bleeding Disorders 27/02/2021


15 Pathogenesis of ITP

 Autoantibodies are directed against platelet membrane


antigens shortening their half life

 The same antibodies may inhibit platelet production

Common Bleeding Disorders 27/02/2021


16 Clinical Features of ITP

 Sudden appearance of petechial rash, bruising and/or


bleeding in an otherwise healthy child

 Preceded by a viral illness within the past month

 Patients appear well and systemic symptoms are


generally absent

Common Bleeding Disorders 27/02/2021


17 Clinical Features of ITP

 No significant enlargement of lymph nodes, liver or


spleen

 Intracranial haemorrhage is a rare complication seen in


less than 1%

Common Bleeding Disorders 27/02/2021


18 Hae

Common Bleeding Disorders 27/02/2021


19 Laboratory Findings

Investigation Results
Full Blood Count Thrombocytopenia
Peripheral Blood Smear Platelets are decreased in number but
of normal size
Bone marrow Normal

Common Bleeding Disorders 27/02/2021


20 Treatment

General Measures:
 Activity restriction
 Avoidance of anticoagulant and antiplatelet medications
 Control of menses
 Education

Specific therapy will depend on the severity of the


bleeding

Common Bleeding Disorders 27/02/2021


21 Treatment

Life threatening bleeding:


 Platelet transfusions
 Methylprednisolone
 Intravenous Immunoglobulin

 When a rapid rise in the platelet count is not required, an


oral glucocorticoid like Prednisolone can be used

Common Bleeding Disorders 27/02/2021


22 Oral glucocorticoids

 Prednisolone 4 mg/kg per day orally for 7 days then


rapid tapering

 Prednisolone 1-2 mg/kg per day orally for 7-21 days then
tapering

Common Bleeding Disorders 27/02/2021


23 Prognosis

 Most children resolve within 3-6 months with or without


treatment

 10-20 % develop chronic ITP

 Chronic ITP is thrombocytopenia persisting beyond 12


months since presentation

Common Bleeding Disorders 27/02/2021


24

Common Bleeding Disorders 27/02/2021


25 What is haemophilia?

 It is an inherited bleeding disorder caused by deficiency


of factor VIII (Hemophilia A), factor IX (Haemophilia B) or
factor XI (Haemophilia C)

 Haemophilia A is more common than Haemophilia B

 Both Haemophilia A and B are inherited in an X-linked


recessive manner

Common Bleeding Disorders 27/02/2021


26

Common Bleeding Disorders 27/02/2021


27 Pathophysiology

 Factors VIII and IX together with phospholipid and


calcium form the factor X activating complex

 In Haemophilia A or B, clot formation is delayed and it is


not robust

 There is inadequate thrombin formation and hence a


tightly linked cross fibrin clot is not generated

Common Bleeding Disorders 27/02/2021


28 Clinical Manifestations

 Symptoms may occur at birth or in the fetus

 30% of male infants bleed with circumcision

 Easy bruising, intramuscular hematomas and


hemarthroses occur when the child begins to cruise

 Hemarthrosis is the hallmark of haemophilia

Common Bleeding Disorders 27/02/2021


29 Clinical Manifestations

 Hemarthroses occur initially in the ankle joints then


become more frequent in the knees and elbows

 Patients complain of a warm, tingling sensation before


swelling becomes apparent

 A joint can develop increased susceptibility to bleeding


once joint damage and inflammation occur (target
joint)

Common Bleeding Disorders 27/02/2021


30 Clinic Manifestations

 Patients may lose large volumes of blood into iliopsoas


muscle with only a vague referred pain in the groin

 The diagnosis is made clinically by the inability to extend


the hip and the maintenance in internal rotation

 Intracranial bleeding is rare but it is one of the most life


threatening events in hemophilia

Common Bleeding Disorders 27/02/2021


31 Laboratory Findings

 Prolonged activated partial thromboplastin time (aPTT)

 Normal platelet and prothrombin time

 Measurement of factor activity level is reduced (< 40 %)

 Normal plasma von Wilebrand antigen factor (VWF: Ag)

Common Bleeding Disorders 27/02/2021


32 Classification of Hemophilia

 Severe hemophilia
 < 1 % of activity of the clotting factor: spontaneous bleeding occurs

 Moderate hemophilia
 1-5% and require moderate trauma to induce bleeding

 Mild haemophilia
 > 5% and may go many years before the condition is diagnosed

Common Bleeding Disorders 27/02/2021


33 Treatment

 For mild to moderate bleeding, factor levels must be


raised to hemostatic levels of 30-50%

 For life threatening or major haemorrhage, the dose


should aim to reach levels of 100%

Common Bleeding Disorders 27/02/2021


34 Dose of Recombinant Factor

Factor VIII (IU) = % desired (rise in FVIII) X body weight (kg) X 0.5

Factor IX (IU)= % desired (rise in FIX) X body weight (kg) X 1.4

Common Bleeding Disorders 27/02/2021


35 Prophylaxis

 It has become the standard in management of patients


with severe haemophilia

 Prophylaxis prevents spontaneous bleeding and early


joint deformity

 Desmopressin Acetate can be used in those with mild


hemophilia

Common Bleeding Disorders 27/02/2021


36 Haemorrhagic Disease of the Newborn

 There is a transient decrease in factors II, VII, IX and X in


all newborns by 48-72 hours after birth

 There is a gradual return to birth levels by 7-10 days

 This is due to lack of free vitamin K from the mother and


absence of intestinal bacterial flora

Common Bleeding Disorders 27/02/2021


37 Classification

• 0-24 hrs
Early Onset • Associated with maternal drugs

• 2-7 days
Classic • In neonates who do not receive Vit K

• 1-6 months
Late Onset • Associated with liver disease

Common Bleeding Disorders 27/02/2021


38 Classic Disease

 The bleeding is gastrointestinal, nasal, subgaleal,


intracranial or postcircumcision

 Breastfed neonates are more at risk

 The PT, blood coagulation time and aPTT are prolonged

 Factors II, VII, IX and X are significantly decreased

Common Bleeding Disorders 27/02/2021


39 Differential Diagnosis

 Disseminated Intravascular Coagulation

 Swallowed blood syndrome

Common Bleeding Disorders 27/02/2021


40 Treatment

 IM administration of Vitamin K, 1 mg prevents the


decrease in vitamin K dependant factors

 It may be treated with a subcutaneous injection of


Vitamin K1, 1-5 mg

 Serious bleeding in premature infants and those with liver


disease may require fresh frozen plasma

Common Bleeding Disorders 27/02/2021


41
References
 Guyton Textbook of Medical Physiology
 Diseases of Children, Stanfield Paget
 Hemophilia, Bree Zimmerman, MD Paediatrics in Review Vol 34, No 7, July
2013
 Nelson Textbook of Paediatrics, 18th Edition
 UpToDate Clinical Manifestations and diagnosis of Haemophilia W Keith
Hoots, MD, Amy D Shapiro, MD
 UpToDate Treatment of bleeding and perioperative management in
Haemophilia A and B

Common Bleeding Disorders 27/02/2021

You might also like